Nifty
Sensex
:
:
10672.25
35406.62
55.55 (0.52%)
146.08 (0.41%)

Pharmaceuticals & Drugs

Rating :
62/99

BSE: 531599 | NSE: FDC

194.25
1.85 (0.96%)
16-Nov-2018 | 11:18AM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  190.65
  •  196.05
  •  190.65
  •  192.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  11743
  •  22.81
  •  319.80
  •  181.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,375.57
  • 20.05
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,346.96
  • N/A
  • 2.49

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.07%
  • 1.71%
  • 14.23%
  • FII
  • DII
  • Others
  • 0.01%
  • 3.75%
  • 11.23%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.30
  • 4.88
  • 2.48

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.39
  • 1.46
  • -0.70

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.27
  • 4.60
  • -0.12

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.15
  • 21.00
  • 21.21

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.78
  • 3.06
  • 3.12

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.85
  • 12.60
  • 13.67

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Dec 17
Dec 16
Var%
Sep 17
Sep 16
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
-
1,075.07
1,013.87
994.32
889.31
845.85
772.83
710.54
711.67
632.14
589.13
Net Sales Growth
-
6.04%
1.97%
11.81%
5.14%
9.45%
8.77%
-0.16%
12.58%
7.30%
 
Cost Of Goods Sold
-
352.08
339.05
357.93
272.91
266.16
311.11
237.54
253.93
221.09
231.93
Gross Profit
-
722.99
674.81
636.38
616.40
579.69
461.71
473.00
457.75
411.05
357.20
GP Margin
-
67.25%
66.56%
64.00%
69.31%
68.53%
59.74%
66.57%
64.32%
65.03%
60.63%
Total Expenditure
-
848.38
770.40
765.58
690.76
641.47
591.97
547.15
545.76
465.62
478.67
Power & Fuel Cost
-
22.00
21.55
23.14
20.18
18.45
16.85
13.77
12.73
11.45
10.20
% Of Sales
-
2.05%
2.13%
2.33%
2.27%
2.18%
2.18%
1.94%
1.79%
1.81%
1.73%
Employee Cost
-
216.67
191.08
175.76
137.58
122.05
107.52
99.02
85.57
68.69
56.10
% Of Sales
-
20.15%
18.85%
17.68%
15.47%
14.43%
13.91%
13.94%
12.02%
10.87%
9.52%
Manufacturing Exp.
-
58.77
49.40
36.44
97.27
88.65
22.88
70.20
67.06
60.66
64.40
% Of Sales
-
5.47%
4.87%
3.66%
10.94%
10.48%
2.96%
9.88%
9.42%
9.60%
10.93%
General & Admin Exp.
-
61.55
53.35
49.97
41.43
35.99
34.32
33.79
31.76
32.39
28.71
% Of Sales
-
5.73%
5.26%
5.03%
4.66%
4.25%
4.44%
4.76%
4.46%
5.12%
4.87%
Selling & Distn. Exp.
-
75.96
64.36
57.73
64.96
58.43
56.15
55.45
55.12
46.74
47.23
% Of Sales
-
7.07%
6.35%
5.81%
7.30%
6.91%
7.27%
7.80%
7.75%
7.39%
8.02%
Miscellaneous Exp.
-
61.35
51.61
64.61
56.43
51.73
43.13
37.36
39.60
24.60
47.23
% Of Sales
-
5.71%
5.09%
6.50%
6.35%
6.12%
5.58%
5.26%
5.56%
3.89%
6.80%
EBITDA
-
226.69
243.47
228.74
198.55
204.38
180.86
163.39
165.91
166.52
110.46
EBITDA Margin
-
21.09%
24.01%
23.00%
22.33%
24.16%
23.40%
23.00%
23.31%
26.34%
18.75%
Other Income
-
50.96
50.22
39.00
45.72
42.00
46.36
28.65
28.25
31.43
12.23
Interest
-
1.40
1.41
1.40
1.81
3.10
1.60
1.41
1.44
1.45
1.77
Depreciation
-
35.14
34.62
33.73
38.81
24.91
27.90
18.43
17.36
15.88
12.91
PBT
-
241.11
257.65
232.62
203.65
218.36
197.72
172.20
175.37
180.62
108.02
Tax
-
67.12
63.30
63.48
55.51
83.04
42.55
38.11
24.48
31.49
21.81
Tax Rate
-
27.84%
25.14%
27.29%
27.26%
38.03%
21.52%
22.13%
13.96%
17.43%
20.19%
PAT
-
173.99
188.47
169.14
148.15
135.32
155.17
134.09
150.89
149.13
86.21
PAT before Minority Interest
-
173.99
188.47
169.14
148.15
135.32
155.17
134.09
150.89
149.13
86.21
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
16.18%
18.59%
17.01%
16.66%
16.00%
20.08%
18.87%
21.20%
23.59%
14.63%
PAT Growth
-
-7.68%
11.43%
14.17%
9.48%
-12.79%
15.72%
-11.13%
1.18%
72.98%
 
Unadjusted EPS
-
9.76
10.60
9.48
8.33
7.59
8.51
7.30
8.11
7.99
4.52

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
1,276.11
1,270.20
1,082.47
936.38
845.30
784.24
695.42
616.39
526.62
422.85
Share Capital
17.52
17.86
17.86
17.86
17.86
18.16
18.37
18.54
18.71
18.90
Total Reserves
1,258.59
1,252.34
1,064.61
918.52
827.43
766.08
677.05
597.86
507.91
403.95
Non-Current Liabilities
211.41
216.67
19.93
24.06
30.97
31.32
30.24
29.59
28.69
24.92
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.22
0.56
0.77
1.27
2.71
Unsecured Loans
0.60
0.69
0.79
0.90
1.07
1.24
1.45
1.73
3.69
3.78
Long Term Provisions
194.12
198.60
0.50
0.56
0.00
0.00
0.00
2.20
0.00
0.00
Current Liabilities
478.99
389.40
163.42
187.97
195.69
153.97
139.01
123.45
123.99
98.50
Trade Payables
97.32
75.10
82.59
87.17
80.05
61.04
57.64
45.90
42.52
36.46
Other Current Liabilities
67.69
64.11
50.16
36.61
42.87
35.98
30.09
29.60
37.31
32.13
Short Term Borrowings
0.00
0.00
0.00
1.00
1.11
1.14
1.29
1.27
0.00
0.00
Short Term Provisions
313.97
250.19
30.67
63.19
71.66
55.81
49.99
46.68
44.16
29.91
Total Liabilities
1,966.51
1,876.27
1,265.82
1,148.41
1,071.96
969.53
864.67
769.43
679.30
546.27
Net Block
673.64
678.05
675.16
393.04
284.40
289.19
293.04
276.74
255.51
242.74
Gross Block
776.49
745.84
708.81
629.67
470.42
453.02
430.01
396.15
358.77
331.50
Accumulated Depreciation
102.84
67.79
33.65
236.62
186.02
163.82
136.96
119.41
103.26
88.75
Non Current Assets
976.64
957.93
742.46
646.27
619.47
558.20
418.02
322.50
285.32
256.13
Capital Work in Progress
12.84
6.32
19.92
28.80
18.10
7.22
10.72
10.18
30.07
27.09
Non Current Investment
74.07
54.49
39.43
216.72
186.92
245.15
96.20
14.01
-0.26
-13.70
Long Term Loans & Adv.
215.28
218.46
7.70
6.37
128.71
15.13
17.41
19.42
0.00
0.00
Other Non Current Assets
0.81
0.60
0.25
1.33
1.33
1.51
0.65
2.15
0.00
0.00
Current Assets
989.86
918.34
523.36
502.13
452.03
410.83
446.10
446.88
393.98
290.14
Current Investments
397.16
436.53
285.41
272.49
229.90
170.91
243.92
248.86
229.42
124.69
Inventories
160.49
137.16
130.91
123.22
103.00
99.71
102.92
97.42
90.25
95.59
Sundry Debtors
81.66
76.06
61.94
61.04
59.36
43.23
41.97
40.75
36.81
35.24
Cash & Bank
29.30
28.47
18.02
14.95
23.43
36.50
16.78
17.76
16.77
12.91
Other Current Assets
321.25
9.68
6.74
15.67
36.33
60.49
40.52
42.09
20.73
21.71
Short Term Loans & Adv.
310.57
230.44
20.36
14.77
28.18
48.89
34.66
39.71
20.73
21.71
Net Current Assets
510.87
528.94
359.94
314.16
256.33
256.86
307.09
323.43
269.99
191.64
Total Assets
1,966.50
1,876.27
1,265.82
1,148.40
1,071.97
969.53
864.66
769.44
679.30
546.27

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
149.84
154.49
174.30
127.64
149.72
149.94
144.33
120.74
168.55
88.52
PBT
240.63
257.71
232.15
203.65
218.36
197.72
172.20
175.37
180.62
108.02
Adjustment
0.35
-10.88
2.41
-1.40
-7.67
-14.20
-2.62
1.31
-6.45
24.55
Changes in Working Capital
-23.20
-19.23
-4.54
-11.78
7.09
4.14
9.01
-20.98
21.18
-27.72
Cash after chg. in Working capital
217.78
227.60
230.02
190.48
217.79
187.66
178.59
155.70
195.35
104.85
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-67.94
-70.14
-55.73
-62.84
-68.07
-37.72
-34.26
-34.97
-26.79
-16.33
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
-2.97
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
20.11
-143.55
-73.05
-88.57
-55.38
-107.18
-108.25
-33.00
-126.95
-51.33
Net Fixed Assets
-36.71
-24.24
-81.62
-169.89
-28.28
-19.51
-25.53
-17.54
-30.20
-55.57
Net Investments
19.79
-166.18
170.44
-72.39
-0.76
-75.95
-83.31
-33.71
-118.17
10.91
Others
37.03
46.87
-161.87
153.71
-26.34
-11.72
0.59
18.25
21.42
-6.67
Cash from Financing Activity
-169.43
0.35
-96.98
-47.76
-75.25
-62.83
-58.18
-57.51
-37.31
-41.70
Net Cash Inflow / Outflow
0.52
11.29
4.27
-8.69
19.09
-20.06
-22.10
30.22
4.29
-4.50
Opening Cash & Equivalents
27.10
16.25
12.17
23.26
4.17
24.23
46.33
16.11
11.81
16.32
Closing Cash & Equivalent
28.13
27.10
16.25
14.56
23.26
4.17
24.23
46.33
16.11
11.81

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
73.17
71.42
60.87
52.62
47.47
43.30
37.95
33.35
28.22
22.42
ROA
9.06%
12.00%
14.01%
13.34%
13.26%
16.92%
16.41%
20.83%
24.34%
16.50%
ROE
13.67%
16.02%
16.76%
16.64%
16.63%
21.01%
20.48%
26.44%
31.48%
21.69%
ROCE
19.04%
21.51%
23.15%
23.02%
27.12%
26.85%
26.34%
30.73%
37.97%
26.92%
Fixed Asset Turnover
1.42
1.44
1.52
1.65
1.87
1.79
1.75
1.91
1.86
2.09
Receivable days
26.58
23.96
22.06
24.19
21.70
19.72
20.88
19.59
20.47
16.60
Inventory Days
50.15
46.55
45.58
45.45
42.89
46.90
50.57
47.41
52.78
56.27
Payable days
41.32
40.83
44.81
47.89
44.12
40.39
37.33
32.94
34.20
32.01
Cash Conversion Cycle
35.41
29.68
22.84
21.74
20.47
26.23
34.12
34.06
39.05
40.85
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.02
Interest Cover
172.62
179.60
167.11
113.30
71.41
124.23
122.88
122.86
125.55
62.12

Annual Reports:

News Update:


  • FDC receives EIR for Aurangabad facility
    31st Oct 2018, 12:38 PM

    The said facility was inspected from August 10, 2018 to August 16, 2018 by USFDA

    Read More
  • USFDA completes inspection at FDC’s sterile ophthalmic manufacturing facility
    21st Aug 2018, 09:19 AM

    The inspection was carried out in relation to the Ophthalmics products being exported to USA market

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.